Rep. Diana DeGette (D-Colo.), co-chair of the Congressional Diabetes Caucus, unveiled a bipartisan bill yesterday that aims to reduce “skyrocketing” costs of insulin in the U.S. The legislation, which DeGette plans to introduce after the congressional recess, would provide insulin manufacturers an “incentive” to set the list price of their insulin at or below the … Continue reading Bloomberg Government: HEALTH CARE BRIEFING: DeGette Pitches Insulin Bill Text